The immunological challenge to developing a vaccine to the blood stages of malaria parasites.
about
Characterization of a conserved rhoptry-associated leucine zipper-like protein in the malaria parasite Plasmodium falciparumAcquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum.Artesunate versus chloroquine infection-treatment-vaccination defines stage-specific immune responses associated with prolonged sterile protection against both pre-erythrocytic and erythrocytic Plasmodium yoelii infection.Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates.High-Level Expression of Immunogenic Recombinant Plasmodium vivax Merozoite Surface Protein (Pvmsp-142 kDa) in pGEX 6P1 Vector.A comparative study of the genetic diversity of the 42kDa fragment of the merozoite surface protein 1 in Plasmodium falciparum and P. vivax.Uninfected mosquito bites confer protection against infection with malaria parasitesAge-shifting in malaria incidence as a result of induced immunological deficit: a simulation study.A Plasmodium-encoded cytokine suppresses T-cell immunity during malariaPre-erythrocytic malaria vaccines: towards greater efficacy.Opsonization of malaria-infected erythrocytes activates the inflammasome and enhances inflammatory cytokine secretion by human macrophages.Dendritic cell biology during malaria.The winding road to developing a malaria vaccine. Study hypothesis.Murine infection models for vaccine development: the malaria example.Diversity and population structure of Plasmodium falciparum in Thailand based on the spatial and temporal haplotype patterns of the C-terminal 19-kDa domain of merozoite surface protein-1Immunomodulation using genetically engineered bacteria for type III-mediated delivery of heterologous antigens and cytokines: potential application in vaccine and therapeutical developments.Antibodies against the Plasmodium falciparum glutamate-rich protein from naturally exposed individuals living in a Brazilian malaria-endemic area can inhibit in vitro parasite growth.Human antibodies to the polymorphic block 2 domain of the Plasmodium falciparum merozoite surface protein 1 (MSP-1) exhibit a highly skewed, peptide-specific light chain distribution.Immunology of malaria infections.
P2860
Q27972927-5CC45E52-760F-4C69-8C98-0BA9B1196183Q33380204-479C71F6-D9F6-431D-B4C7-8DA66828D236Q33927133-83BA56A9-B8F4-4A3B-8584-C5D6A25540C5Q34161839-D6F4B164-BB6D-48D0-890E-1CA635ACB8FEQ35668254-EAD8FB2C-A35A-49CF-A082-B5A70354E7FDQ35754172-77C325C6-593E-4F1B-9340-54172385D74BQ35784007-62853A26-018A-4117-B3D0-037A7967529FQ35885315-E82C061D-6FAC-4FAF-9A3B-B3E372C97549Q36140303-91A9FB86-B390-4B3C-AD55-5A8C61B39091Q36403400-F6A059FE-3B5D-4F5F-8906-E8D41DECE648Q36483344-B1C8B0E5-09CF-4661-997C-D962BD3E1E25Q36705307-CE1AC794-9625-4C43-96A5-7003742FB12EQ37441617-223F92C7-B97C-4693-A530-7B5981A2E34BQ37478246-02C72DEF-DA7A-4133-9791-48720AC6B517Q37597218-741211EB-FD2D-4AAE-B25F-2D8C3017CBC5Q37602699-2F3203AF-8601-4C22-ACAC-CFF5286962BBQ44575916-1A06D636-6BDF-4FD0-A5DC-7674B3BD5E6BQ48012530-7FD80BFE-9DF9-44C7-8A75-FFD05289E705Q48023150-233DDE5B-DB66-47A0-ADE0-7E91AF5AA51A
P2860
The immunological challenge to developing a vaccine to the blood stages of malaria parasites.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The immunological challenge to ...... d stages of malaria parasites.
@ast
The immunological challenge to ...... d stages of malaria parasites.
@en
type
label
The immunological challenge to ...... d stages of malaria parasites.
@ast
The immunological challenge to ...... d stages of malaria parasites.
@en
prefLabel
The immunological challenge to ...... d stages of malaria parasites.
@ast
The immunological challenge to ...... d stages of malaria parasites.
@en
P2093
P2860
P1476
The immunological challenge to ...... od stages of malaria parasites
@en
P2093
Danielle Stanisic
Salenna Elliott
P2860
P304
P356
10.1111/J.0105-2896.2004.00178.X
P577
2004-10-01T00:00:00Z